BCAR1 and breast cancer: Correspondingly, elevated expression of p130Cas in human patients is associated with early disease recurrence and poor prognosis in several cancer types, including lung, prostate, pancreas, ovarian, and mammary cancers (Cabodi et al., 2010a; Defilippi et al., 2006; Fromont and Cussenot, 2011; Fromont et al., 2007; Nick et al., 2011; Nikonova et al., 2014; Tikhmyanova et al., 2010) and is associated with hormone deprivation‐mediated resistance to antitumor drugs (standard therapeutics) such as adriamycin (doxorubicin) and tamoxifen (Dorssers et al., 2001; Ta et al., 2008).